This information was published on 2025-09-04T02:12:32 for IP Right Filed Published.
| Field | Value |
| (210) | 2583543 (IR 1873243) |
| (220) |
16 May 2025
|
| (300) |
US, 02 Apr 2025, 99116433
|
| (511) (510) |
Class 5
Pharmaceutical products for the treatment of cancer; biologics in the nature of pharmaceutical preparations for the treatment of cancer; antibodies for medical purposes, namely, for the treatment of cancer. |
| (540) | CRESCENT BIOPHARMA |
| (550) | Word |
| (730) |
Crescent Biopharma, Inc.
|
Find out more about publications on the About page.